Ziconotide Injection

Ziconotide Injection
Details:
1.General Specification(in stock)
(1)API(Pure powder)
(2)Injection
(3)Tablets
2.Customization:
We will negotiate individually, OEM/ODM, No brand, for secience researching only.
Internal Code: KP-3-51/002
ziconotide CAS 107452-89-1
Molecular formula: C102H172N36O32S7
Main market: USA, Australia, Brazil, Japan, Germany, Indonesia, UK, New Zealand , Canada etc.
Analysis: HPLC, LC-MS, HNMR
Technology support: R&D Dept.-4
Send Inquiry
Description
Send Inquiry

Ziconotide injection, marketed as Prialt, is an artificially synthesized omega conotoxin MVIIA, which belongs to the category of intrathecal analgesics. It was approved for market by the US FDA and the European Union in 2004. This drug is suitable for severe chronic pain patients who have not responded to other analgesic treatments (such as systemic analgesics or intrathecal morphine), especially for cancer pain and refractory neuropathic pain. Its mechanism of action is to specifically block the N-type voltage-gated calcium channel (CaV2.2) in the spinal dorsal horn, inhibit the release of pain neurotransmitters, and has the characteristics of non addiction, non tolerance, and high safety of discontinuation.

 
Products form
 
Ziconotide peptide | Shaanxi BLOOM Tech Co., Ltd
Ziconotide injection | Shaanxi BLOOM Tech Co., Ltd
Ziconotide tablets | Shaanxi BLOOM Tech Co., Ltd

Ziconotide Price List | Shaanxi BLOOM Tech Co., Ltd

Ziconotide Price List | Shaanxi BLOOM Tech Co., Ltd

​ Method of Analysis | Shaanxi BLOOM Tech Co., Ltd

Ziconotide Polyacetate COA

  Shaanxi BLOOM Tech Co., Ltd
Certificate of Analysis
Compound name Ziconotide Polyacetate
Grade Pharmaceutical grade
CAS No. 107452-89-1
Quantity 30g
Packaging standard PE bag+Al foil bag
Manufacturer Shaanxi BLOOM TECH Co., Ltd
Lot No. 202601090088
MFG Jan 9th 2026
EXP Jan 8th 2029
Structure

Ziconotide structure | Shaanxi BLOOM Tech Co., Ltd

Item Enterprise standard Analysis result
Appearance White or almost white powder Conformed
Water content ≤5.0% 0.54%
Loss on drying ≤1.0% 0.42%
Heavy Metals Pb≤0.5ppm N.D.
As≤0.5ppm N.D.
Hg≤0.5ppm N.D.
Cd≤0.5ppm N.D.
Purity (HPLC) ≥99.0% 99.98%
Single impurity <0.8% 0.52%
Total microbial count ≤750cfu/g 95
E. Coli ≤2MPN/g N.D.
Salmonella N.D. N.D.
Ethanol (by GC) ≤5000ppm 500ppm
Storage Store in a sealed, dark, and dry place below -20°C

Ziconotide NMR | Shaanxi BLOOM Tech Co., Ltd

 

 Shaanxi BLOOM Tech Co., Ltd

Chemical Formula: C97H170N34O30S5
Exact Mass: 2511
Molecular Weight: 2513
m/z: 2511 (100.0%), 2513 (95.3%), 2511 (40.8%), 2513 (22.6%),2511 (21.5%), 2454 (17.2%), 2453 (12.6%), 2452 (12.0%), 2455 (11.7%), 2453 (11.2%), 2454 (6.5%), 2454 (6.2%), 2453 (5.9%), 2455 (4.5%), 2453 (4.0%), 2456 (3.9%), 2452 (3.8%), 2455 (2.8%), 2454 (2.7%), 2455 (2.5%), 2456 (2.0%), 2453 (2.0%), 2455 (1.9%), 2452 (1.9%), 2454 (1.6%), 2456 (1.5%), 2455 (1.4%), 2456 (1.4%), 2455 (1.3%), 2453 (1.1%), 2452 (1.1%), 2456 (1.1%), 2457 (1.0%)
Elemental Analysis: C, 47.50; H, 6.99; N, 19.42; O, 19.57; S, 6.54

The existing dosage forms include injection solutions with concentrations of 25mg/ml and 100mg/ml, which are administered intrathecally through implantable or external infusion pumps. Common adverse reactions involve nervous system (dizziness, ataxia), digestive system (nausea) and urinary system (urinary retention). Contraindications include a history of allergies, mental illness, intracranial infections, and bleeding. The drug is metabolized by peptidase and excreted in the form of amino acids, with less than 1% of the original drug excreted in urine.

 

Usage | Shaanxi BLOOM Tech Co., Ltd

 

Cancer pain is one of the most common, complex, and persistent symptoms in cancer patients during and after treatment, seriously affecting their health status and quality of life. Despite an increase in the assessment and management of pain related to cancer treatment, the prevalence of pain remains as high as 55%. Although traditional opioid drugs can provide a certain degree of analgesic effect, they have problems such as side effects and addiction, leading to insufficient pain relief. Ziconotide injection, as a non opioid analgesic, provides a new option for the treatment of cancer pain.

1. Intractable cancer pain

Ziconotide pain | Shaanxi BLOOM Tech Co., Ltd

In the field of cancer pain treatment, it is mainly used to overcome the difficult problem of intractable cancer ache. Difficult to treat cancer ache refers to ache conditions that cannot be effectively controlled even with comprehensive interventions of traditional analgesics and adjuvant therapy, or where patients cannot tolerate treatment due to drug side effects and other reasons. Traditional analgesic drugs cover a wide range, including nonsteroidal anti-inflammatory drugs, which mainly exert antipyretic, analgesic, and anti-inflammatory effects by inhibiting the synthesis of prostaglandins in the body. Common ones include ibuprofen, aspirin, etc; Weak opioid drugs, such as codeine, have relatively weak analgesic effects but also carry a certain risk of addiction; Strong opioid drugs, such as morphine and fentanyl, are commonly used potent analgesics in clinical practice, but long-term use can easily lead to tolerance and addiction. Adjuvant therapy drugs include antidepressants, such as amitriptyline, which can improve the emotional state of patients and indirectly alleviate ache by regulating neurotransmitters;

Anticonvulsant drugs, such as carbamazepine, are mainly used to treat neuropathic ache by stabilizing nerve cell membranes to alleviate pain.

The causes of this type of intractable cancer pain are quite complex.
On the one hand, tumors themselves have strong invasiveness and may directly invade nerves, bones, or internal organs. When tumors invade nerves, they can disrupt the normal structure and function of nerves, leading to abnormal nerve signal transmission and causing severe ache. For example, tumor compression of spinal nerves can cause radiating ache, which may involve multiple limbs or body areas. When tumors invade bones, they can damage bone tissue and cause bone ache, which is usually severe and worsens during activity. When tumors invade internal organs, they can cause organ dysfunction and ache. For example, liver cancer invading the liver capsule can cause persistent bloating and pain in the upper right abdomen.

Ziconotide uses | Shaanxi BLOOM Tech Co., Ltd
Ziconotide drug | Shaanxi BLOOM Tech Co., Ltd

On the other hand, various methods used in tumor treatment, such as surgery, radiotherapy, chemotherapy, etc., may also cause nerve damage. During the surgical process, peripheral nerves may inevitably be damaged, leading to postoperative ache syndrome. Radiotherapy, while killing tumor cells, may also cause damage to surrounding normal tissues, leading to radiation-induced neuropathy and ache. Chemotherapy drugs have certain toxicity and may cause damage to the nervous system, leading to neuropathic ache.

Case support: In the rich cases of clinical practice, many cancer ache patients are deeply troubled by the poor efficacy of traditional analgesics. Take a patient with advanced pancreatic cancer as an example. pancreatic cancer itself is famous for its high malignancy and strong pain symptoms. After diagnosis, the patient actively received standardized treatment.

In terms of ache management, the doctor used high-dose hydrocodone sustained-release tablets and hydromorphone according to the routine protocol. Hydroxyketone sustained-release tablets are a strong opioid drug that exerts analgesic effects by binding to opioid receptors, providing sustained and stable ache relief. Hydromorphone is also a potent analgesic with rapid onset and relatively short duration of action. However, despite the use of these two potent analgesics, the patient's pain control remains unsatisfactory. Frequent outbreaks of ache occur, with severe intensity during each episode, causing unbearable pain to the patient and seriously affecting their daily life, such as eating, sleeping, and activities, leading to a significant decline in their quality of life.

Ziconotide treatment | Shaanxi BLOOM Tech Co., Ltd
Ziconotide sick | Shaanxi BLOOM Tech Co., Ltd

In this case, after comprehensive evaluation, the doctor decided to switch the patient to intrathecal injection of Ziconotide for treatment. Intrathecal injection is a method of administering drugs directly into the subarachnoid space, which can quickly reach the site of action, improve the efficacy of drugs, and reduce the side effects caused by systemic medication. After a period of intrathecal injection therapy with Ziconotide, a miracle occurred and the patient's ache was significantly relieved. The frequency of explosive pain attacks has significantly decreased, and the degree of ache has also been greatly reduced. Patients can eat, sleep, and engage in some simple activities normally, and their quality of life has been significantly improved. This case fully demonstrates the effectiveness and unique advantages of Ziconotide in treating refractory cancer pain.

Information source: Welcome to the website of the editorial department of the Chinese Journal of Pain Medicine! (Qinyun Journal) published "Rational drug use • Application of patient-controlled analgesia technology in the treatment of refractory pain of pancreatic cancer 11 mg cancer pain" 

2. Specific types of cancer pain

 

Ziconotide injection has shown good therapeutic effects on various types of cancer pain, including background pain and explosive pain, two common pain types that cause great ache to patients. Background ache is a persistent pain that troubles patients like an invisible shackle. This type of pain may be caused by factors such as continuous compression, invasion, or inflammatory response of the tumor. The degree of pain is relatively stable, but it will persist for a long time, seriously affecting the patient's daily life and psychological state. Patients may feel exhausted, anxious, and depressed due to persistent background ache, greatly reducing their quality of life. Explosive pain, on the other hand, is a sudden and intense pain that is unpredictable and often strikes without the patient's defense, catching them off guard. The frequency and intensity of explosive pain attacks vary from person to person. Some patients may experience it several times a day, while others may experience it once a few days.

Ziconotide various | Shaanxi BLOOM Tech Co., Ltd

 

Ziconotide pain | Shaanxi BLOOM Tech Co., Ltd

However, the pain level during each attack is extremely severe, like a knife cut or electric shock, causing great pain to the patient. Due to the difficulty in predicting and controlling explosive ache, patients face greater challenges during the treatment process.

By continuous intrathecal injection, it can directly act on the N-type calcium channels in the spinal dorsal horn, exerting its unique analgesic effect. For background ache, the transmission of ache signals can be continuously and stably suppressed, effectively controlling pain and maintaining the patient's ache level at a low level, thereby improving the patient's quality of life. For explosive pain, it can reduce its frequency and intensity of onset. It reduces the occurrence of explosive pain by regulating the excitability of the nervous system and decreasing the sensitivity of neurons to ache stimuli. Meanwhile, its sustained effect can maintain the stable state of spinal dorsal horn neurons and prevent explosive pain caused by excessive excitation of neurons.

 

Research data: In order to further validate the effectiveness of Ziconotide injection in treating specific types of cancer ache, a significant multicenter study involving 200 cancer ache patients was conducted for in-depth exploration. In this study, researchers strictly followed scientific research design and standards to administer intrathecal injection therapy to 200 patients with different types and stages of cancer pain, and conducted a 12 week close observation and follow-up. The research results showed that after 12 weeks of intrathecal injection therapy, 65% of patients achieved ache relief of 30% or more. This data fully demonstrates its significant effect in relieving cancer ache. More importantly, the study also found a significant decrease in the frequency of explosive ache attacks in patients. This means that after receiving treatment, patients not only effectively control their background ache, but also significantly improve the explosive ache that has been troubling them for a long time. Patients can face their illness and life more calmly, and their quality of life has been substantially improved.

Ziconotide ache | Shaanxi BLOOM Tech Co., Ltd

Information source: "Side effects and precautions of Prialt Ziconotide" published by Zhihu Column

FAQ
 

Is ziconotide stronger than morphine?

These studies have revealed that ziconotide is more potent than morphine and is particularly efficacious in models of persistent pain (duration measured in minutes to hours) and chronic pain (duration measured in hours to days).

Is ziconotide a peptide?

Ziconotide (also known as SNX-111) is a neurotoxic peptide derived from the cone snail Conus magus comprising 25 amino acids with three disulphide bonds.

When was ziconotide approved by the FDA?

Ziconotide was granted FDA approval on December 28, 2004 for marketing by TerSera therapeutics LLC. under the name Prialt. To date, ziconotide is the only calcium channel blocking peptide approved for use by the FDA.

What is ziconotide made of?

A synthetic, nonopiod, twenty-five amino acid polybasic peptide analogue of an omega-conotoxin derived from the marine snail Conus magus with analgesic activity.

 

Hot Tags: ziconotide injection, China ziconotide injection manufacturers, suppliers, salcatonin injection, intranasal desmopressin acetate, best glp 1 peptide, desmopressin sublingual tablet, glp1 shot, etelcalcetide structure

Send Inquiry